"Science, regardless of whether it's academic or industrial, is a passionate and intense activity and you really need to enjoy the process behind it. If you do, then the interface between academia and industry can be quite blurred."
Paul Kellam is VP of Infectious Diseases & Vaccines at Kymab, as well as a Professor of Virus Genomics at Imperial College London. As a virologist, he has worked to tackle some of the biggest threats to human health, including HIV, ebola, cancer and of course covid-19.